Literature DB >> 8662737

Invasion of the CAG triplet repeats by a complementary peptide nucleic acid inhibits transcription of the androgen receptor and TATA-binding protein genes and correlates with refolding of an active nucleosome containing a unique AR gene sequence.

L C Boffa1, P L Morris, E M Carpaneto, M Louissaint, V G Allfrey.   

Abstract

The DNA sequence of the genes for the androgen receptor (AR) and TATA-binding protein (TBP), like many other genes encoding transcription factors, contains a series of tandem CAG repeats. Here we explore the capacity of complementary peptide nucleic acids (PNAs) to invade the CAG triplets of the AR and TBP genes in human prostatic cancer cells and show that the PNAs readily entered the nuclei of lysolecithin-permeabilized cells and effectively inhibited sense transcription of unique AR and TBP DNA sequences downstream of the site of PNA.DNA hybridization, but not upstream of that site. These PNAs had little or no effect on transcription of the c-myc gene, which lacks a CAG triplet domain. Conversely, a PNA complementary to a unique sequence of the c-myc gene did not inhibit transcription of the AR or TBP genes but did inhibit c-myc transcription. Comparisons of PNA effects on sense and antisense transcription of the AR, TBP, and c-myc genes confirm that progression of the RNA polymerase complex beyond the site of PNA.DNA hybridization is impaired in both directions. Suppression of the AR gene results in refolding of a transcriptionally active nucleosome containing a unique 17-mer AR DNA sequence.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8662737     DOI: 10.1074/jbc.271.22.13228

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

Review 1.  Peptide nucleic acids: versatile tools for gene therapy strategies.

Authors:  D A Dean
Journal:  Adv Drug Deliv Rev       Date:  2000-11-15       Impact factor: 15.470

2.  A simple model for gene targeting.

Authors:  T Ratilainen; P Lincoln; B Nordén
Journal:  Biophys J       Date:  2001-11       Impact factor: 4.033

Review 3.  The peptide nucleic acids (PNAs): introduction to a new class of probes for chromosomal investigation.

Authors:  Franck Pellestor; Petra Paulasova
Journal:  Chromosoma       Date:  2004-05-19       Impact factor: 4.316

Review 4.  PNA Technology.

Authors:  Peter E Nielsen
Journal:  Mol Biotechnol       Date:  2004-03       Impact factor: 2.695

5.  Targeting peptide nucleic acid (PNA) oligomers to mitochondria within cells by conjugation to lipophilic cations: implications for mitochondrial DNA replication, expression and disease.

Authors:  A Muratovska; R N Lightowlers; R W Taylor; D M Turnbull; R A Smith; J A Wilce; S W Martin; M P Murphy
Journal:  Nucleic Acids Res       Date:  2001-05-01       Impact factor: 16.971

6.  Peptide nucleic acid-targeted mutagenesis of a chromosomal gene in mouse cells.

Authors:  A F Faruqi; M Egholm; P M Glazer
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

7.  Chemotherapeutic deletion of CTG repeats in lymphoblast cells from DM1 patients.

Authors:  Vera I Hashem; Malgorzata J Pytlos; Elzbieta A Klysik; Kuniko Tsuji; Mehrdad Khajavi; Merhdad Khajav; Tetsuo Ashizawa; Richard R Sinden
Journal:  Nucleic Acids Res       Date:  2004-12-01       Impact factor: 16.971

8.  Blockade of plasmid replication mediated by peptide nucleic acids.

Authors:  Michael R Liebling; Nainn-Tsyr Jou; Wayne Fang; James S Louie
Journal:  Mol Biotechnol       Date:  2003-11       Impact factor: 2.695

9.  PNA binding to the non-template DNA strand interferes with transcription, suggesting a blockage mechanism mediated by R-loop formation.

Authors:  Boris P Belotserkovskii; Philip C Hanawalt
Journal:  Mol Carcinog       Date:  2014-08-30       Impact factor: 4.784

10.  Creation of a novel peptide with enhanced nuclear localization in prostate and pancreatic cancer cell lines.

Authors:  H Dan Lewis; Ali Husain; Robert J Donnelly; Dimitrios Barlos; Sheraz Riaz; Kalyani Ginjupalli; Adetola Shodeinde; Beverly E Barton
Journal:  BMC Biotechnol       Date:  2010-10-28       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.